Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.
Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.
复制标题
DOI:
10.1016/j.trsl.2021.03.011
复制
发表时间:
2021-08
期刊:
影响因子:
--
通讯作者:
Lambdin BH
中科院分区:
文献类型:
--
作者:
Wenger LD;Kral AH;Bluthenthal RN;Morris T;Ongais L;Lambdin BH
As COVID-19 accelerated throughout 2020, syringe service programs (SSPs) faced challenges necessitating programmatic adaptations to prevent overdose deaths while simultaneously keeping workers and participants safe from COVID-19. We used qualitative methods to gain an understanding of the social context within which SSPs are operating during the COVID-19 pandemic. We conducted 36 in-depth interviews with program representatives from 18 programs and used the Exploration, Preparation, Implementation, Sustainment (EPIS) implementation framework to guide data analysis. We focused on 3 of the 4 EPIS constructs: Outer context, inner context, and innovation factors. Our data indicate that responding to the pandemic led to innovations in service delivery such as secondary and mail-based distribution, adoption of telemedicine for enrolling participants in medications for opioid use disorder (MOUD) and use of virtual training platforms for overdose prevention. We found high levels of staff and volunteer commitment, which was a cornerstone to the success of these innovations. We observed that many SSPs were short-staffed because of their commitment to safety, and some lost current funding as well as opportunities for future funding. Despite minimal staffing and diminished funding, SSPs innovated at an accelerated pace. To ensure the sustainability of these new approaches, a supportive external context (federal, state, and local policies and funding) is needed to support the development of SSPs’ inner contexts (organizational characteristics, characteristics of individuals) and sustainment of the innovations achieved regarding delivery of naloxone and MOUD.
登录
查看更多内容
DOI:
10.1097/qai.0b013e3181f9c0b6
发表时间:
2010-12
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Friedland G
通讯作者:
Friedland G
DOI:
10.1007/s11524-010-9495-8
发表时间:
2010-12
影响因子:
6.6
作者:
Enteen, Lauren;Bauer, Joanna;McLean, Rachel;Wheeler, Eliza;Huriaux, Emalie;Kral, Alex H.;Bamberger, Joshua D.
通讯作者:
Bamberger, Joshua D.
影响因子:
3.9
作者:
Cioe K;Biondi BE;Easly R;Simard A;Zheng X;Springer SA
通讯作者:
Springer SA
影响因子:
4.4
作者:
Abdul-Quader AS;Feelemyer J;Modi S;Stein ES;Briceno A;Semaan S;Horvath T;Kennedy GE;Des Jarlais DC
通讯作者:
Des Jarlais DC
影响因子:
12.7
作者:
Bluthenthal, Ricky N.;Heinzerling, Keith G.;Kral, Alex H.
通讯作者:
Kral, Alex H.